Enhanced lymphatic exposure of a chemotherapeutic drug with pegylated, nano-sized drug vectors
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: RYAN, Gemma (Monash University, Pharmaceutics, Melbourne, Australia)
- Co-author(s): Kaminskas, Lisa (Monash University, Melbourne, Australia)
Bulitta, J (Monash University, Melbourne, Australia)
Michelle, Mcintosh (Monash University, Melbourne, Australia)
Owen, David (Starpharma Pty Ltd, Melbourne, Australia)
Porter, Chris (Monash University, Melbourne, Australia)
I. Background: The treatment of lymph-resident cancers presents a challenge, since small molecule chemotherapeutic drugs typically have limited lymphatic access. Nano-sized drug carriers can improve lymphatic drug targeting, although to this point, it is not known which drug carriers optimally increase lymphatic exposure.
II. Aims: To assess the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.